WSI Investments

Total investments

1

Average round size

20M

Portfolio companies

1

Areas of investment
Health CareHealth DiagnosticsMedical Device

Summary

The important activity for fund was in 2005. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the WSI Investments, startups are often financed by Sequel Venture Partners, Cardinal Partners, Primus Capital Partners. The meaningful sponsors for the fund in investment in the same round are Sequel Venture Partners, Primus Capital Partners, Novo Holdings. In the next rounds fund is usually obtained by Sequel Venture Partners, Primus Capital Partners, Novo Holdings.

Among the most popular portfolio startups of the fund, we may highlight CardioOptics, CardioOptics. Among the most popular fund investment industries, there are Health Care, Health Diagnostics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
1
Lead investments
0
Investments by industry
  • Health Care (1)
  • Medical Device (1)
  • Health Diagnostics (1)
Investments by region
  • United States (1)
Peak activity year
2005

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CardioOptics 14 Dec 2005 Health Care, Health Diagnostics, Medical Device Early Stage Venture 20M United States, Massachusetts
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.